AZN | tickerfilter.com

Fundamental analysis

46%

Profitability 29%

Dept financing 44%

Liquidity 48%

Performance 62%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.50%

1 Month

-4.49%

3 Months

-0.73%

6 Months

-8.47%

1 Year

-7.83%

2 Year

-5.71%

Key data

Stock price

$69.57

P/E Ratio

5.61

DAY RANGE

$68.80 - $69.79

EPS

$1.92

52 WEEK RANGE

$61.24 - $87.68

52 WEEK CHANGE

-$7.83

MARKET CAP

101.570 B

YIELD

3.77%

SHARES OUTSTANDING

3.101 B

DIVIDEND

$1.05

EX-DIVIDEND DATE

02-21-2025

NEXT EARNINGS DATE

04-29-2025

BETA

0.17

PUBLIC FLOAT

AVERAGE 10 VOLUME

$4,657,487

AVERAGE 30 VOLUME

$6,742,033

Company detail

CEO: Pascal Soriot
Region: US
Website: astrazeneca.com
Employees: 83,500
IPO year: 1993

Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. The company serves primary care and specialty care physicians through distributors in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia.

AZN - ASTRAZENECA PLC